On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.
Exposure to tobacco smoke, which includes second-hand or passive exposure, allergens, irritants in the air, and extreme weather conditions are the major risk factors driving the global chronic obstructive pulmonary disease treatment.Wilmington, Delaware, United States, Aug. 09, 2023 (GLOBE NEWSWIRE) The global chronic obstructive pulmonary disease (COPD) treatment market is projected to flourish at a CAGR of 4.4% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 30.4 b